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Abstract
Introduction: Sodium ferulate (SF) is a natural component of traditional Chinese herbs. Our previous study shows
that SF has a protective effect on osteoarthritis (OA). The objective of this study was to investigate the effect of SF
on the TNF/TNF receptor (TNFR) signal transduction pathway of rat OA chondrocytes.
Methods: Primary rat articular chondrocytes were co-treated with IL-1b and SF. Chondrocyte apoptosis was
assessed by fluorescein isothiocyanate-annexin V/propidium iodide assay. The PCR array was used to screen the
expression of 84 key genes involved in apoptosis. The release of TNFa and prostaglandin E2 were analyzed by
ELISA. Expressions of proteins were assessed by western blotting. The activity of NF-B was determined by
electrophoretic mobility shift assay (EMSA). Gene expression of inducible nitric oxide synthase (iNOS) was evaluated
by real-time quantitative PCR. The nitric oxide content was measured with the Griess method.
Results: After treatment with SF, the apoptosis rate of chondrocytes significantly attenuated (P < 0.01). Results of
the apoptosis PCR array suggested that mRNA expression of some core proteins in the TNF/TNFR pathway showed
valuable regulation. The protein expressions of TNFa, TNFR-1, TNF receptor-associated death domain, caspase-8
and caspase-3 were prevented by SF in a concentration-dependent manner. SF also inhibited activities of caspase-8
and caspase-3 compared with the OA model control (P < 0.01). TNF receptor-associated factor-2 expression,
phosphorylations of inhibitor of NF-B kinase (IKK) subunits alpha and beta, and NF-B inhibitor, alpha (IBa) were
all concentration-dependently suppressed by SF treatment. The results of EMSA showed that SF inhibited the
activity of NF-B. In addition, the expressions of cycloxygenase-2 and iNOS and the contents of prostaglandin E2
and NO were attenuated with the treatment of SF (P < 0.01).
Conclusion: SF has anti-apoptosis and anti-inflammatory effects on an OA model induced by IL-1b in vitro, which
were due to inhibitory actions on the caspase-dependent apoptosis pathway and the IKK/NF-B signal
transduction pathway of the TNF/TNFR pathway.
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Introduction
Osteoarthritis (OA) is the most common arthropathy of
load-bearing articulating joints in humans and animals.
OA is grossly characterized by the degeneration of articu-
lar cartilage and the loss of cartilage matrix in affected
joints. The pathological process of the disease involves
changes in the survival of chondrocytes and is often asso-
ciated with an inflammatory response. Chondrocytes are
the only cells in articular cartilage, which play an impor-
tant role in maintaining matrix integrity, pathological
cascade process and tissue homeostasis. Beyond the com-
pensation capability of chondrocytes in the OA process,
apoptosis cells become the main source of various cata-
bolic factors, such as proteases, proinflammatory media-
tors [1], nitric oxide (NO) and oxygen radicals [2].
Chondrocyte survival or apoptosis and inflammation are
therefore important in the pathogenesis of OA.
Over the past decade, apoptosis has been identified as a
critical factor responsible for cell loss in ageing OA carti-
lage. Many important mediators, including IL-1b, TNFa,
caspase-8 and caspase-3, are involved in OA chondrocyte
apoptosis [3]. IL-1b is one of the main cytokines that has
been implicated in the pathogenesis of OA. This cytokine
induces large-scale apoptosis in chondrocytes, which
leads to further degenerative changes in cartilage [4,5].
Moreover, it has been suggested that IL-1b induces the
expression of the TNFa gene in chondrocytes [6] and
upregulates the surface expression of TNF receptor
(TNFR) [7]. The death receptor, mitochondrial and endo-
plasmic reticulum pathways are concluded to be the
major cellular pathways of apoptosis [8]. These pathways
are distinct in initiation and signaling, but a significant
overlap exists in regulatory and effector mechanisms.
The best known examples of death receptors include Fas
and TNFR [4]. Upon binding of the respective ligand,
protein interaction modules are used to assemble a
receptor signaling complex called the death inducing sig-
naling complex. This complex recruits and activates the
upstream initiator caspases, including caspase-8, which
leads, in turn, to the activation of effector caspases (cas-
pase-3, caspase-6, caspase-7) and to internucleosomal
DNA fragmentation [4].
Inflammation is another promoting factor in the OA
process, including chondrocyte and synovium inflamma-
tion [9]. The majority of the proinflammatory proteins
linked to arthritis are regulated by the transcription factor
NF-B, which regulates the expression of a wide variety of
genes [10]. Combination of TNF and TNFR activates TNF
receptor-associated factor (TRAF)-2 to lead to the phos-
phorylation of inhibitor of NF-B kinase (IKK). The IKK
family consists of two catalytic subunits (IKKa and IKKb)
and a noncatalytic regulatory subunit (IKKg) [11]. The
canonical NF-B signaling (RelA:p50) relies upon IKKg-
IKKb-mediated degradation of NF-B inhibitor, alpha
(IBa), and the noncanonical NF-B signaling (RelB:p52)
relies upon NF-B inducing kinase and IKKa [12,13].
Yong and colleagues showed that IKKb is the main IKK
catalytic subunit responsible for IBa signal response
domain phosphorylation in response to proinflammatory
stimuli in chondrocytes [14]. In response to extracellular
stimuli, such as TNFa and IL-1b, the transcription factor
NF-B is often activated and subsequently facilitates the
transcription of a number of genes involved in inflamma-
tion, such as cyclooxygenase-2 (COX-2), inducible nitric
oxide synthase (iNOS), and specific cytokines [15]. The
induced iNOS catalyzes the formation and release of a
large amount of NO, which then plays a key role in OA
pathophysiology. Induced by several stimuli, COX-2 is
responsible for the production of large amounts of proin-
flammatory prostaglandins at the inflammatory site [16].
Sodium ferulate (SF), a sodium salt of ferulic acid (3-
methoxy-4-hydroxy-cinnamate sodium), is a natural
component of traditional Chinese herbs and some food-
stuffs. SF can be easily synthesized and is widely used in
scientific research and clinical treatment [17-21]. Various
beneficial effects of SF have been reported, including as
an antioxidant [17], for the removal of free radicals
[18,19], anti-inflammatory actions [20] and anti-apoptotic
activity [21]. Recently, for the first time our laboratory
showed the beneficial effect of SF on OA [22]. We
showed that SF reverses cartilage degradation processes
and inhibits expressions of matrix metalloproteinase-1
and BAX in a rat OA model in vivo. We also showed that
SF prevents chondrocytes apoptosis, represses NO synth-
esis and attenuates the levels of matrix metalloprotei-
nase-1/tissue inhibitor of metalloproteinase-1 to prevent
extracellular matrix degradation in human OA chondro-
cytes [22]. However, the precise molecular mechanism
responsible for SF’s anti-apoptosis and anti-inflammatory
effects in chondrocytes is not yet clear. According to the
screen results of an apoptosis RT2 profile PCR array, the
aim of the present study was to investigate the effect of
SF on the TNF/TNFR signal transduction pathway,
including the caspase-dependent apoptosis pathway and




SF was provided by YaoYou Medicine (Chongqing, China;
0.1 g/ampere, SFDA approval number H50021634). IL-1b
was purchased from PeproTech (Rocky Hill, NJ, USA).
Annexin V conjugated to fluorescein isothiocyanate
(annexin-V-FITC) and propidium iodide (PI) were from
Jingmei Biotech (Wuhan, China). The Rat Apoptosis RT2
Profiler PCR array PARN-012 and the RT2 First Strand kit
were purchased from SABiosciences (Frederick, MD,
USA). TNFa and prostaglandin E2 (PGE2) ELISA kits
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were obtained from R&D Systems (Minneapolis,
MN, USA). Rabbit anti-TNFR-1 polyclonal antibody, anti-
TNF receptor-associated death domain (anti-TRADD),
anti-TRAF-2, anti-IKKa, anti-phospho-IKKa, anti-IKKb,
anti-phospho-IKKb, anti-IBa, anti-phospho-IBa, anti-
caspase-3, anti-COX-2, anti-glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) and horseradish peroxidase-
conjugated anti-rabbit were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit anti-
caspase-8 was purchased from BoAoSen Biotech (Wuhan,
China). The Membranous, Nuclear and Cytoplasmic Pro-
tein Extraction Kit, the BCA Protein Assay Kit and the cas-
pase-3, caspase-8 Activity Assay Kit were obtained from
Beyotime Biotech (Shanghai, China). The enhanced chemi-
luminescence kit and biotin-labeled double-stranded oligo-
nucleotide probes were provided by Pierce Biotech
(Rockford, IL, USA) and Viagen Biotech (Los Angeles, CA,
USA), respectively. All other reagents were sourced from
Sigma-Aldrich (Saint Louis, MO, USA), unless otherwise
indicated.
Chondrocyte culture and treatment
Animal care and treatment were in accordance with the
Guidelines of the Laboratory Animal Management and
Review Committee of Wuhan University (China). Male
Wistar rats (130 to 150 g, Animal Center of Wuhan Uni-
versity) were housed under controlled temperature and
lighting conditions with food and water. Articular carti-
lage isolated from femoral head cap pieces was aseptically
dissected, and chondrocytes were obtained after digestion
of cartilage fragments in 0.25% trypsin (w/v) for 30 min-
utes followed by about 6 to 7 hours of digestion in 0.2%
collagenase II (w/v) in DMEM without serum. Chondro-
cytes were cultured at a density of 105 cells/ml in DMEM
with 10% fetal bovine serum. Experiments were per-
formed with first-passage cultures. SF was prepared with
sterile distilled water and diluted with DMEM. The con-
centration of SF was selected on the basis of our previous
study [22]. Chondrocytes were divided into six groups:
normal control group, chondrocytes without any treat-
ments; OA model control group, chondrocytes treated
with 20 ng/ml IL-1b; and SF treatment groups, OA
model chondrocytes treated with 20 ng/ml IL-1b and
125, 250, 500 or 1,000 μmol/l SF, respectively. Chondro-
cytes were serum starved and co-treated with 125, 250,
500 or 1,000 μmol/l SF and 20 ng/ml IL-1b for 48 hours
after incubation with the different concentrations SF
mentioned above alone for 24 hours. To investigate
whether different concentrations of SF themselves pre-
sent cytotoxicity on chondrocyte (detection of cell viabi-
lity), normal chondrocytes were treated with 125, 250,
500 or 1,000 μmol/l SF, respectively, for 72 hours, fol-
lowed by an assay of cell viability. These experiments
were performed in triplicate and the results are provided
as mean values from three independent experiments.
Chondrocyte viability assay
After chondrocytes had been cultured in 96-well flasks
(104 cells/well) for 48 hours, 125, 250, 500 or 1,000
μmol/l SF were added for 72 hours, respectively. The
medium was then replaced with DMEM containing
5 mg/ml 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-
tetrazolium bromide and incubated for 4 hours at
37°C. Formazan products were dissolved in 100 μl
dimethylsulfoxide and absorbance was measured at
570 nm using a microplate reader (Shimadzu, Kyoto,
Japan).
Detection of apoptosis
Chondrocytes were resuspended in 200 μl HEPES buffer,
and stained with 5 μl annexin-V-FITC and 10 μl PI for
15 minutes at room temperature in the dark. After incuba-
tion, 200 μl HEPES buffer was added, and the cells were
measured by EPICS ALTRAII flow cytometry (Beckman,
Fullerton, CA, USA) and analyzed with Multi-cycle soft-
ware (Phoenix Flow Systems, San Diego, CA, USA).
Results were expressed as the percentage of (PI-negative
and annexin-V-positive) apoptotic cells. All experiments
were performed in triplicate.
Chondrocyte apoptosis PCR array and real-time
quantitative PCR
Total RNAs were extracted from chondrocytes using TRI-
zol (Invitrogen, Carlsbad, CA, USA) following the manu-
facturer’s instructions. RNA concentrations were
measured using the Nanodrop method (3300 NanoDrop
Analyzer; Thermo Scientific, Wilmington, NC, USA).
Equal amounts of RNA per sample (1 μg) were used for
the RT2 First Strand kit. Comparison of the relative
expression of 84 apoptosis-related genes was performed
using the RT2 Profiler PCR array PARN-012 (Rat Apopto-
sis PCR Array; SABiosciences) on an ABI Fast 7500 ther-
mocycler using RT2 Real-Time SYBR Green PCR master
mix PA-012 (SABiosciences, Frederick, MD, USA).
Hypoxanthine phosphoribosyltransferase-1, GAPDH, and
b-actin (ACTB) housekeeping genes were used for nor-
malization and data were analyzed with the ΔΔCt (thresh-
old cycle) method. The real-time PCR primers for
GAPDH and iNOS were designed corresponding to the
coding region of the genes as follows: GAPDH, sense 5’-
GGCTCTCTGCTCCTCCCTGT-3’ and antisense 5’-GTA
ACCAGGCGTCCGATACGGC-3’; iNOS, sense 5’-TTCT
GTGCTAATGCGGAAGGT-3’ and antisense 5’-GCTTC
CGACTTTCCTGTCTCA-3’. After an initial incubation
for 15 minutes at 95°C, the reactions were carried out for
40 cycles at 95°C for 15 seconds and 60°C for 30 seconds
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(florescence collection). The expression of iNOS was nor-
malized to the GAPDH gene to standardize comparison.
Enzyme-linked immunosorbent assay
Chondrocytes were cultured and stimulated as described
above and supernatants were collected after 72 hours.
The release of TNFa and PGE2 were analyzed by ELISA
kits (R&D Systems, Minneapolis, MN, USA) according to
the manufacturer’s instructions. The optical density of
each well was determined within 30 minutes, using a
microplate reader set to 450 nm. TNFa and PGE2 values
are expressed as picograms per milliliter.
Western blotting analysis
Chondrocyte monolayers were washed three times with cold
PBS and cell proteins were extracted on ice by the Membra-
nous, Nuclear and Cytoplasmic Protein Extraction Kit with
1 mmol/l phenylmethyl sulfonylfluoride. The protein con-
centration of different extracts was determined according to
the BCA Protein Assay Kit using BSA as a standard. After
adjusting to equal amounts (50 μg protein per lane) of pro-
teins, they were separated on SDS-PAGE (5 and 12% gels)
under reducing conditions and transferred to polyvinylidene
difluoride membranes. Membranes were blocked and
probed with anti-rat TNFR-1 (1:200), TRAF-2 (1:400), IKKa
(1:300), phospho-IKKa (1:300), IKKb (1:300), phospho-
IKKb (1:300), IBa (1:300), phospho-IBa (1:300), COX-2
(1:400), GAPDH (1:300), anti-rat caspase-8 (1:200), caspase-
3 (1:200) or TRADD (1:200) primary antibodies, then incu-
bated with horseradish peroxidase-conjugated secondary
antibodies (goat anti-rabbit IgG, 1:3,000), followed with
visualization by the enhanced chemiluminescence kit.
Caspase protease activity assay
Caspase activity was determined by a colorimetric assay
based on the ability of caspase-3 and caspase-8 to change
acetyl-Asp-Glu-Val-Asp p-nitroanilide (Ac-DEVD-pNA)
and acetyl-Ile-Glu-Thr-Asp p-nitroanilide (Ac-IETD-pNA)
into a yellow formazan product of p-nitroaniline, respec-
tively. An increase in absorbance at 405 nm was used to
quantify the activation of caspase activity. The collected
chondrocytes were rinsed with cold PBS, and then lysed by
lysis buffer (40 μl) for 15 minutes on ice. Cell lysates were
centrifuged at 16,000 × g for 10 minutes at 4°C. Caspase-3
and caspase-8 activities in the supernatant were assayed
with the caspase-3, caspase-8 Activity Assay Kit. An activity
unit was defined as the amount of enzyme that will cleave
1.0 nmol colorimetric substrate Ac-DEVD-pNA or
Ac-IETD-pNA per hour at 37°C under saturated substrate
concentrations. Total protein contents were determined
according to the BCA Protein Assay Kit and the caspase
activity was expressed as activity units compared with total
protein content (unit/μg protein). All of the experiments
were carried out in triplicate.
NF-B activity assay
Nuclear extracts (5 mg per reaction) were incubated with
biotin-labeled double-stranded oligonucleotide probes
(P1, 5’-AGTTGAGGGGACTTTCCCAGGC-3’; P2, 3’-
TCAACT CCCCTGAAAGGGTCCG-5’; Viagen Biotech)
for 20 minutes at room temperature. Reactions were frac-
tionated on nonreducing 6.5% polyacrylamide gel and
transferred to nylon membranes, then incubated with
streptonuclide-horseradish peroxidase and visualized.
Nitrite assay
NO production was measured as nitrite (NO2
-) in the cul-
ture medium. As reported previously [22], nitrite was
detected by the Griess reaction using sodium nitrite as the
standard. Absorbance at 550 nm was measured on a UV-
1601 spectrophotometer (Shimadzu, Kyoto, Japan). The
nitrite concentration was calculated and expressed in
micromoles per liter.
Statistical analysis
Results are presented as the mean ± standard error of the
mean. After testing for normal distribution (Kolmogorov-
Smirinov), a paired Student’s t test was used to compare
data between groups. To analyze the effects of treatments,
two-way analysis of variance for repeated measures with
appropriate post hoc comparisons (Student-Newman-
Keuls) was performed. P < 0.05 was considered significant.
Results
Assay of cell viability
Monolayer cultured chondrocyte viability in the SF group
was significantly higher than in the control group at 500
and 1,000 μmol/l dosages (P < 0.01; n = 8). However, 125
and 250 μmol/l SF had no effect on increasing cell viabi-
lity. All of these results show that different concentrations
of SF from 125 to 1,000 μmol/l have no effect on normal
chondrocyte viability (Figure 1).
Chondrocyte apoptosis
Chondrocyte apoptosis was identified by FITC-annexin
V/PI double-labeled assay. IL-1b significantly increased
the percentage of apoptotic chondrocytes in model con-
trol compared with the normal control (P < 0.01; n = 4).
With treatments of 250, 500 and 1,000 μmol/l SF, the
apoptotic percentage of OA chondrocytes was attenu-
ated in a concentration-dependent manner (all P < 0.01;
n = 4). However, 125 μmol/l SF failed to prevent OA
chondrocyte apoptosis (Figure 2).
Chondrocyte apoptosis PCR array
The Rat Apoptosis RT2 Profiler PCR array analysis was
performed for expression of 84 apoptosis genes in the
normal control, model control and 1,000 μmol/l SF
treatment groups. The array included TNF ligands and
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their receptors (TRAFs), Bcl2 family members, caspases,
inhibitor of apoptosis, caspase recruitment domain
family members, death domain, death effector domain,
and cell death-inducing DFFA-like effector family mem-
bers, as well as the genes involved in the p53 and DNA-
damaged induced apoptosis and ataxia telangiectasia
mutated pathways. Each reported value represents the
mean fold of mRNA expression relative to the control
levels for three biological replicates. To focus on parti-
cular pathways, a cutoff value for the fold-change ≥2.0
was taken. The mRNA expression of TNF increased
30.07-fold after stimulation by IL-1b. The mRNA
expressions of TNFR-1B, TRAF-2, TRADD, Fas-
associated death domain protein, caspase-8, caspase-3
and NF-B increased respectively after stimulation by
IL-1b versus normal control. However, SF could reduce
the mRNA expressions of these core proteins respec-
tively after treatment with SF versus the OA model
control (Table 1).
Caspase cascade apoptosis pathway induced by TNF/TNF
receptor
ELISA showed that IL-1b induced the large-scale release
of TNFa (P < 0.01; n = 3). Western blotting clearly
showed a similar GAPDH content in each group and an
increase in TNFR-1, TRADD, caspase-8 and caspase-3
expression contents in the model control compared
with normal control. Treatment with 250, 500 and 1,000
μmol/l SF can obviously inhibit each protein expression
induced by IL-1b in a concentration-dependent manner,
especially on caspase-8 and caspase-3 (all P < 0.01; n =
3) (Figure 3a,b).
IL-1b significantly increased activities of caspase-8 and
caspase-3 in the model group (both P < 0.01; n = 3).
However, SF concentration-dependently attenuated the
activities of caspase-8 and caspase-3 in OA chondro-
cytes at 250 to 1,000 μmol/l, except for 250 μmol/l SF
on caspase-3 (all P < 0.01 or 0.05; n = 3). Treatment
with 125 μmol/l SF had no effect on activities of cas-
pase-8 and caspase-3 in OA chondrocytes (Figure 3c).
IKK/NF-B pathway induced by TNF/TNF receptor
Expressions of protein TRAF-2, phospho-IKKa, phos-
pho-IKKb and phospho-IBa were induced by IL-1b,
but IKKa, IKKb and IBa expressions were similar
with the normal control. Concentration-dependent
attenuations in TRAF-2, phospho-IKKa, phospho-
IKKb and phospho-IBa protein expressions were
markedly present after treatment of 500 and 1,000
μmol/l SF (all P < 0.01; n = 3), but IKKa, IKKb and
IBa protein expressions showed no obvious alteration
(n = 3). The GAPDH content was similar in each lane
(Figure 4a,b,c,d,e).
EMSA results showed that IL-1b markedly increased
the binding activity of NF-B to DNA, but SF inhibited
this activity in a concentration-dependent manner com-
pared with the model control (Figure 4f).
Expressions of COX-2 and PGE2 induced by IL-1b
increased in the model control (both P < 0.01, n = 3).
SF concentration-dependently attenuated COX-2
expression and PGE2 release (all P < 0.01, n = 3). IL-1b
significantly increased the gene expression of iNOS and
NO synthesis in the model group (both P < 0.01; n = 3).
However, SF concentration-dependently inhibited the
gene expression of iNOS and NO synthesis with the
exception of the 125 μmol/l SF treatment group in NO
content (Figure 5a,b,c,d).
Figure 1 Effect of sodium ferulate on proliferation of normal
rat chondrocytes. After chondrocytes had been cultured in a 96-
well plate for 48 hours, 125, 250, 500 or 1,000 μmol/l sodium
ferulate (SF) were added for 72 hours, respectively. Values represent
mean ± standard error of the mean of eight different wells. **P <
0.01 versus control (0). OD, optical density.
Figure 2 Effect of sodium ferulate on the apoptosis rate of IL-
1b-induced rat osteoarthritis chondrocytes. Chondrocytes were
incubated with sodium ferulate (SF) alone for 24 hours, and then co-
treated with IL-1b and SF for 48 hours. After staining with annexin-V-
fluorescein isothiocyanate and propidium iodide, chondrocytes were
measured on flow cytometry and analyzed with Multi-cycle software
(Phoenix Flow Systems, San Diego, CA, USA). Results expressed as
percentage of apoptotic cells. Values represent mean ± standard
error of the mean of four different simples. **P < 0.01 versus normal
control. ##P < 0.01 versus osteoarthritis model control.
Qin et al. Arthritis Research & Therapy 2012, 14:R242
http://arthritis-research.com/content/14/6/R242
Page 5 of 12
Discussion
IL-1b is a proinflammatory cytokine in OA pathogenesis,
which is widely used on chondrocytes to establish an OA
model in vitro [23,24]. Pathologic effects of IL-1b include:
inhibition of chondrocyte proliferation and synthesis of
collagen II and proteoglycan in the extracellular matrix
[25]; increase of cartilage catabolic enzyme activity, such
as matrix metalloproteinases, which lead to degradation of
extracellular matrix [26]; promotion of NO, free radical
and inflammatory factor synthesis [27]; and activation of
some intracellular key factors on the signal pathway, such
as NF-B [28]. When NF-B is activated by IL-1b, gene
expressions of TNFa, iNOS and COX-2 obviously increase
[28-31]. Further research showed that NF-B reached the
activity peak at 30 minutes after treatment of IL-1b, and
then attenuated to an undetectable level [32]. Notably, at
this time, OA progress was still aggravated because of
abundant factors, such as TNFa, iNOS and COX-2,
induced by activated NF-B. Moreover, it has been con-
firmed that IL-1b might upregulate surface expression of
TNFR [7]. Such autocrine and paracrine loops perpetuate
joint destruction, frequently resulting in irreversible dis-
ease progression. IL-1b can also induce chondrocyte apop-
tosis to establish an experimental apoptosis model [33].
Our previous findings corroborated the abovementioned
effects of IL-1b in primary human OA chondrocytes [22].
SF prevented these sequential effects, but the precise
mechanism responsible for its anti-apoptosis and anti-
inflammatory effects is not yet clear. In the present study,
taking into account the exaggerative increase of TNF gene
expression (30.07-fold) in the apoptosis PCR array after
treatment of IL-1b for 48 hours, we concluded that abun-
dant TNFa induced by IL-1b initiated the TNF/TNFR sig-
nal pathway for chondrocyte apoptosis and inflammation
at that time point. The ELISA results also confirmed that
IL-1b could induce protein expression of TNFa in
chondrocytes.
Combination of TNF and TNFR on the cell membrane
can activate the downstream signal pathway. Research
shows that a combination of TNF/TNFR induces two sig-
nal pathways: the caspase cascade apoptosis pathway and
the IKK/NF-B pathway [34] (Figure 6). Oligomerization
of TNF/TNFR by their ligands induces recruitment of
adaptor proteins such as Fas-associated death domain pro-
tein and TRADD. These adaptor proteins bind to the cyto-
plasmic tail of receptors through homologous death
domain interactions. Procaspase-8 is recruited into the
complex via homologous death effector domain interac-
tions, forming death inducing signaling complex. The
initiator caspases activate executioner caspases. Active
executioner caspases (caspase-3) cleave the death sub-
strates, which eventually results in apoptosis [35]. In the
present study, SF concentration-dependently prevented
the percentage of apoptotic chondrocytes induced by IL-
1b. The screening results from the RT² Profiler Apoptosis
PCR Array showed that SF attenuated the gene expres-
sions of TNFR-1, TRADD, caspase-8 and caspase-3, which
were related to the TNF/TNFR-induced caspase cascade
Table 1 Effects of 1,000 μmol/l sodium ferulate on apoptosis-related gene expression in rat osteoarthritis
chondrocytes.
Gene Model control/normal control (20 ng/ml vs. 0 ng/
ml IL-1b)
SF treatment/model control (1,000 μmol/l vs. 0 μmol/l SF in presence


















Caspase 9 0.53 0.48
Each reported value represents the mean fold of mRNA expression relative to the control levels for three biological replicates. FADD, Fas-associated death
domain protein; SF, sodium ferulate; TNFR, tumor necrosis factor receptor; TRADD, TNF receptor-associated death domain; TRAF, TNF receptor-associated factor.
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apoptosis pathway. The results of western blotting and
ELISA showed a similar alteration tendency on these pro-
teins, in which SF attenuated the expressions of TNFa,
TNFR-1, TRADD, caspase-8 and caspase-3 proteins and
the activities of caspase-8 and caspase-3. We speculate
that the TNF/TNFR-induced caspase cascade apoptosis
pathway may be the molecular mechanism involved in the
anti-apoptosis effect of SF on OA.
In addition, recruitment of TRADD after combination
of TNF/TNFR activates TRAF-2 to lead to the phosphor-
ylation of IKK. The canonical NF-B signaling (RelA:
p50) relies upon IKKg-IKKb-mediated degradation of
IBa, and the noncanonical NF-B signaling (RelB:p52)
relies upon NF-B inducing kinase and IKKa [12,13].
Recent analyses revealed that synthesis of the constitu-
ents of the noncanonical pathway is controlled by cano-
nical IKKb-IB-RelA:p50 signaling [36]. Moreover,
generation of the canonical and noncanonical dimers
within the cellular milieu is also mechanistically inter-
linked [36]. A broad range of stimuli can activate the NF-
B dimer by triggering a signaling pathway that leads to
the phosphorylation of IKK. Activated NF-B translo-
cates into the nucleus and binds with specific genes
involved in inflammation for regulation of transcription
[26], such as TNFa, iNOS and COX-2 [37,38]. In addi-
tion to the alternation on the caspase cascade apoptosis
Figure 3 Effects of sodium ferulate on the caspase cascade apoptosis pathway in rat osteoarthritis chondrocytes. Effects of sodium
ferulate (SF) on the TNF/TNF receptor (TNFR)-mediated caspase cascade apoptosis pathway of rat osteoarthritis (OA) chondrocytes induced by
IL-1b. (a) Effects of SF on expression of TNFa in rat OA chondrocytes. Chondrocytes were incubated with SF alone for 24 hours, and then co-
treated with IL-1b and SF for 48 hours. Supernatants were collected after 72 hours. Release of TNFa was analyzed by ELISA. (b) Effects of SF on
protein expression of TNFR-1, TNF receptor-associated death domain (TRADD), caspase-8, caspase-3 and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) in rat OA chondrocytes. Expression of proteins determined by western blotting. (c) Effects of SF on activity of caspase-8
and caspase-3 in rat OA chondrocytes. An activity unit was defined as the amount of enzyme that will cleave 1.0 nmol colorimetric substrate
(acetyl-Asp-Glu-Val-Asp p-nitroanilide or acetyl-Ile-Glu-Thr-Asp p-nitroanilide) per hour at 37°C under saturated substrate concentrations. Caspase
activity was expressed as activity units compared with total protein content (unit/μg pro). (d, e, f, g) Relative level of TNFR-1, TRADD, caspase-8
and caspase-3 normalized to GAPDH and compared with normal control, quantitatively analyzed by Kodak Digital Science 1D software (Eastman
Kodak, Rochester, NY, USA) and expressed as mean optical density. Values represent mean ± standard error of the mean of three different
simples. **P < 0.01 versus normal control. #P < 0.05, ##P < 0.01 versus OA model control.
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pathway, the PCR array showed that the executing factor
NF-B of the IKK/NF-B pathway was attenuated by SF.
We therefore determined the relative proteins in the
TNF/TNFR-induced IKK/NF-B pathway and inflamma-
tory factors downstream. These results showed that the
expressions of protein TRAF-2, phospho-IKKa, phos-
pho-IKKb and phospho-IBa were markedly prevented
in a concentration-dependent manner after treatment of
SF in chondrocytes induced by IL-1b. After IBa is
rapidly phosphorylated it is ubiquitinated and then sub-
sequently degraded by the proteosome within the next 1
or 2 hours at most [39]. IBa-NF-B signaling has multi-
ple interacting negative feedback loops and an autoregu-
latory pathway [39,40]. In the present model, we found
Figure 4 Effects of sodium ferulate on the IKK/NF-B signaling pathway of rat osteoarthritis chondrocytes. Effects of sodium ferulate (SF)
on the TNF/TNF receptor (TNFR)-mediated IKK/NF-B signaling pathway of rat osteoarthritis (OA) chondrocytes induced by IL-1b. (a) Effects of SF
on protein expression of TNF receptor-associated factor 2 (TRAF-2), inhibitor of NF-B kinase (IKK) subunit alpha (IKKa), IKK subunit beta (IKKb),
NF-B light polypeptide gene enhancer in B-cell inhibitor, alpha (IBa), phosphorylation of IKKa (p-IKKa), phosphorylation of IKKb (p-IKKb),
phosphorylation of IBa (p-IBa) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in rat OA chondrocytes. Chondrocytes were
incubated with SF alone for 24 hours, and then co-treated with IL-1b and SF for 48 hours. Expressions of proteins determined by western
blotting. (b, c, d, e) Relative level of TRAF-2, IKKa, IKKb, IBa, p-IKKa, p-IKKb and p-IBa normalized to GAPDH and compared with normal
control, quantitatively analyzed by Kodak Digital Science 1D software (Eastman Kodak, Rochester, NY, USA) and expressed as mean optical
density. Values represent mean ± standard error of the mean of three different simples. **P < 0.01 versus normal control. ##P < 0.01 versus OA
model control. (f) Effects of SF on activity of NF-B in rat OA chondrocytes. Nuclear extracts were incubated with biotin-labeled double-stranded
oligonucleotide probes. Reactions were fractionated on nonreducing 6.5% polyacrylamide gel and transferred to nylon membranes, then
incubated with streptonuclide-horseradish peroxidase and visualized. NS, nonspecific free DNA band.
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that total IBa protein levels did not change after IL-1b
treatment of 24 to 48 hours. Perhaps this is due to con-
tinuous stimulation by IL-1b. Further studies are needed
to elucidate the precise mechanism of SF on IBa at the
early stage in OA chondrocytes induced by IL-1b. What
is more, our EMSA experiment showed that SF inhibited
the binding activity of NF-B to DNA compared with the
model control but could not define precise NF-B subu-
nits. In the model control group, iNOS gene expression
and COX-2 protein expression obviously were increased
with intervention of IL-1b. However, SF prevented the
increases of iNOS gene expression and COX-2 protein
expression in the model group. The contents of NO and
PGE2 were also attenuated with the treatment of SF.
Combined with changes of relative proteins (such as
TNFa, TNFR-1 and TRAF-2), the binding activity of NF-
B and expressions of downstream inflammatory genes
(such as COX-2, iNOS, PGE2 and NO), we speculate that
SF can attenuate the TNF/TNFR-induced inflammation
of OA chondrocytes, which might be due to the suppres-
sion of the IKK/NF-B signaling pathway.
Recently, SF has been approved by State Drugs
Administration of China as a drug for treatment of car-
diovascular and cerebrovascular diseases [41,42], diabetic
nephropathy [43] and neurodegenerative disorders [44].
The safety and efficacy of SF have been demonstrated in
clinical practice. Our previous study showed that
intraarticular administration of SF can reduce cartilage
degradation processes in a rat OA model in vivo [22].
The present research revealed the precise molecule
(a)   
(d)   
(c)   
(b)   
Figure 5 Effects of sodium ferulate on cycloxygenase-2, prostaglandin E2, inducible nitric oxide synthase, and nitric oxide. Effects of
sodium ferulate (SF) on cycloxygenase-2 (COX-2), prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS) and nitric oxide (NO) expression
and synthesis of rat osteoarthritis (OA) chondrocytes induced by IL-1b. (a) Effects of SF on protein expression of COX-2 and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) in rat OA chondrocytes. Chondrocytes were incubated with SF alone for 24 hours, and then co-treated with
IL-1b and SF for 48 hours. Expression of COX-2 and GAPDH determined by western blotting. (b) Effects of SF on gene expression of iNOS and
GAPDH in rat OA chondrocytes. Level of iNOS was evaluated by real-time quantitative PCR. (c) Effects of SF on NO synthesis of rat OA
chondrocytes induced by IL-1b. NO production was measured as nitrite (NO2
-) in the culture medium by the Griess reaction. NO concentration
was calculated (expressed in μmol/l). (d) Effects of SF on expression of PGE2 in rat OA chondrocytes. The release of PGE2 was analyzed by ELISA
and the concentration was calculated (expressed in pg/ml). Values represent mean ± standard error of the mean of three different simples. **P <
0.01 versus normal control. ##P < 0.01 versus OA model control.
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mechanism responsible for the anti-apoptosis and anti-
inflammatory effects of SF in chondrocytes. All these
observations provide the scientific basis for the clinical
application of SF on OA.
Conclusion
Our findings indicate that SF can prevent apoptosis of
chondrocytes in vitro, due to the inhibitory action of the
caspase-dependent pathway of the TNF/TNFR signal
transduction pathway. SF can also attenuate the TNF/
TNFR-induced inflammation of OA chondrocytes and
downregulate the NO synthesis and PGE2 release,
which might be due to suppression of the IKK/NF-B
signaling pathway. From our study, the effective protec-
tion of SF in OA chondrocytes in vitro is involved not
only in the anti-apoptosis process but also in the anti-
inflammatory effect.
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